Display options
Cite
Dubois-Deruy E, Peugnet V, Turkieh A, et al. Oxidative Stress in Cardiovascular Diseases. Antioxidants (Basel). 2020;9(9)doi: 10.3390/antiox9090864.
Dubois-Deruy, E., Peugnet, V., Turkieh, A., & Pinet, F. (2020). Oxidative Stress in Cardiovascular Diseases. Antioxidants (Basel, Switzerland), 9(9), . https://doi.org/10.3390/antiox9090864
Dubois-Deruy, Emilie, et al. "Oxidative Stress in Cardiovascular Diseases." Antioxidants (Basel, Switzerland) vol. 9,9 (2020). doi: https://doi.org/10.3390/antiox9090864
Dubois-Deruy E, Peugnet V, Turkieh A, Pinet F. Oxidative Stress in Cardiovascular Diseases. Antioxidants (Basel). 2020 Sep 14;9(9). doi: 10.3390/antiox9090864. PMID: 32937950; PMCID: PMC7554855.
Copy Download .nbib Format: NLM
Share it on

Antioxidants (Basel). 2020 Sep 14;9(9). doi: 10.3390/antiox9090864.

Oxidative Stress in Cardiovascular Diseases.

Antioxidants (Basel, Switzerland)

Emilie Dubois-Deruy, Victoriane Peugnet, Annie Turkieh, Florence Pinet

Affiliations

  1. Inserm U1167, Institut Pasteur de Lille, Université de Lille, 59000 Lille, France.

PMID: 32937950 PMCID: PMC7554855 DOI: 10.3390/antiox9090864

Abstract

Reactive oxygen species (ROS) are subcellular messengers in signal transductions pathways with both beneficial and deleterious roles. ROS are generated as a by-product of mitochondrial respiration or metabolism or by specific enzymes such as superoxide dismutases, glutathione peroxidase, catalase, peroxiredoxins, and myeloperoxidases. Under physiological conditions, the low levels of ROS production are equivalent to their detoxification, playing a major role in cellular signaling and function. In pathological situations, particularly atherosclerosis or hypertension, the release of ROS exceeds endogenous antioxidant capacity, leading to cell death. At cardiovascular levels, oxidative stress is highly implicated in myocardial infarction, ischemia/reperfusion, or heart failure. Here, we will first detail the physiological role of low ROS production in the heart and the vessels. Indeed, ROS are able to regulate multiple cardiovascular functions, such as cell proliferation, migration, and death. Second, we will investigate the implication of oxidative stress in cardiovascular diseases. Then, we will focus on ROS produced by NAPDH oxidase or during endothelial or mitochondrial dysfunction. Given the importance of oxidative stress at the cardiovascular level, antioxidant therapies could be a real benefit. In the last part of this review, we will detail the new therapeutic strategies potentially involved in cardiovascular protection and currently under study.

Keywords: antioxidant; cardiovascular diseases; kinase; mitochondria; oxidative stress; reactive oxygen species

References

  1. PLoS One. 2016 Dec 28;11(12):e0168283 - PubMed
  2. Physiol Rev. 2014 Jul;94(3):909-50 - PubMed
  3. Front Physiol. 2017 Jun 27;8:428 - PubMed
  4. Redox Biol. 2019 Sep;26:101292 - PubMed
  5. PLoS One. 2009;4(5):e5557 - PubMed
  6. Nutr Res. 2020 Jun;78:11-26 - PubMed
  7. Clin Interv Aging. 2018 Apr 26;13:757-772 - PubMed
  8. Mol Cell Biochem. 2010 Jan;333(1-2):191-201 - PubMed
  9. Cell Mol Life Sci. 2020 Feb;77(3):455-465 - PubMed
  10. Cardiovasc Res. 2012 Jan 1;93(1):79-88 - PubMed
  11. Redox Biol. 2013 Feb 08;1:244-57 - PubMed
  12. Circulation. 2002 Mar 26;105(12):1429-35 - PubMed
  13. Circ Res. 2013 Jan 18;112(2):393-405 - PubMed
  14. J Biol Chem. 2010 Mar 12;285(11):8375-82 - PubMed
  15. J Mol Cell Cardiol. 2015 May;82:48-58 - PubMed
  16. Front Physiol. 2020 Jul 02;11:694 - PubMed
  17. J Am Coll Cardiol. 2011 Feb 1;57(5):577-85 - PubMed
  18. Exp Gerontol. 2020 Mar;131:110821 - PubMed
  19. Am J Physiol Heart Circ Physiol. 2019 Mar 1;316(3):H639-H646 - PubMed
  20. J Am Coll Cardiol. 2009 Nov 10;54(20):1891-8 - PubMed
  21. Free Radic Biol Med. 2005 Jun 1;38(11):1458-70 - PubMed
  22. Am J Physiol Heart Circ Physiol. 2020 Mar 1;318(3):H682-H695 - PubMed
  23. J Am Heart Assoc. 2016 Jan 11;5(1): - PubMed
  24. Diabetes. 2006 Jan;55(1):209-15 - PubMed
  25. Clin Exp Pharmacol Physiol. 2008 Apr;35(4):483-8 - PubMed
  26. Cells. 2020 Feb 17;9(2): - PubMed
  27. Circ Res. 2001 Mar 16;88(5):529-35 - PubMed
  28. Am J Cardiol. 2012 Aug 1;110(3):356-63 - PubMed
  29. J Clin Med. 2020 Jun 25;9(6): - PubMed
  30. Circ Res. 2012 Sep 28;111(8):1091-106 - PubMed
  31. J Am Heart Assoc. 2020 Aug 4;9(15):e016862 - PubMed
  32. N Engl J Med. 2006 Apr 13;354(15):1578-88 - PubMed
  33. J Am Coll Cardiol. 2017 Jul 11;70(2):230-251 - PubMed
  34. Circ Res. 2000 Jun 9;86(11):1129-34 - PubMed
  35. J Physiol. 2014 Apr 15;592(8):1873-86 - PubMed
  36. J Am Coll Cardiol. 2017 Jul 11;70(2):196-211 - PubMed
  37. Expert Rev Cardiovasc Ther. 2016 Dec;14(12):1305-1313 - PubMed
  38. PLoS One. 2018 Feb 13;13(2):e0192624 - PubMed
  39. J Mol Cell Cardiol. 2012 Feb;52(2):330-40 - PubMed
  40. Int J Mol Sci. 2019 Feb 19;20(4): - PubMed
  41. Circ Res. 2010 Jul 23;107(2):228-32 - PubMed
  42. Chem Biol Interact. 2015 Feb 5;227:89-95 - PubMed
  43. Clin Sci (Lond). 2018 Jul 18;132(13):1471-1485 - PubMed
  44. Nutr Res. 2011 Nov;31(11):842-7 - PubMed
  45. J Clin Invest. 1993 Jan;91(1):308-18 - PubMed
  46. Biomed Pharmacother. 2020 Jul;127:110234 - PubMed
  47. J Mol Cell Cardiol. 2020 Jan;138:165-174 - PubMed
  48. Ann Med. 2011 Jun;43(4):259-72 - PubMed
  49. Biochim Biophys Acta Mol Basis Dis. 2017 May;1863(5):1066-1077 - PubMed
  50. Cardiovasc Res. 2009 Feb 15;81(3):449-56 - PubMed
  51. JAMA. 2005 Jul 6;294(1):56-65 - PubMed
  52. Cell Death Dis. 2019 Nov 4;10(11):835 - PubMed
  53. Free Radic Biol Med. 2016 Jan;90:12-23 - PubMed
  54. Ageing Res Rev. 2018 Jul;44:33-48 - PubMed
  55. Antioxid Redox Signal. 2012 Jun 1;16(11):1295-322 - PubMed
  56. Circ Res. 2000 Nov 10;87(10):840-4 - PubMed
  57. Biochim Biophys Acta Mol Basis Dis. 2020 Jul 1;1866(7):165768 - PubMed
  58. Hypertension. 2002 Oct;40(4):477-84 - PubMed
  59. JAMA. 2004 Feb 4;291(5):565-75 - PubMed
  60. Nutr Rev. 1992 Jan;50(1):7-12 - PubMed
  61. BMC Cardiovasc Disord. 2017 Jun 19;17(1):161 - PubMed
  62. Nutrients. 2019 Sep 04;11(9): - PubMed
  63. Circ Res. 2010 Jul 9;107(1):106-16 - PubMed
  64. Front Physiol. 2015 Jul 07;6:194 - PubMed
  65. J Cardiovasc Pharmacol. 2018 Nov;72(5):231-241 - PubMed
  66. JAMA. 2005 Mar 16;293(11):1338-47 - PubMed
  67. Prog Biophys Mol Biol. 2018 Dec;140:5-12 - PubMed
  68. Am J Physiol Heart Circ Physiol. 2011 Dec;301(6):H2181-90 - PubMed
  69. Am J Physiol Heart Circ Physiol. 2009 Jul;297(1):H153-62 - PubMed
  70. PLoS One. 2014 Aug 12;9(8):e104788 - PubMed
  71. Cell Metab. 2011 Nov 2;14(5):612-22 - PubMed
  72. J Am Heart Assoc. 2016 May 05;5(5): - PubMed
  73. Front Pharmacol. 2016 Nov 09;7:397 - PubMed
  74. Int Heart J. 2017 Aug 3;58(4):577-583 - PubMed
  75. Circ Heart Fail. 2015 Jan;8(1):128-37 - PubMed
  76. Circ Res. 2011 Apr 1;108(7):837-46 - PubMed
  77. J Am Coll Cardiol. 2017 Jul 11;70(2):212-229 - PubMed
  78. Curr Cardiol Rev. 2018 Mar 14;14(1):53-59 - PubMed
  79. Arterioscler Thromb Vasc Biol. 2005 Dec;25(12):2554-9 - PubMed
  80. PLoS One. 2015 Mar 19;10(3):e0118393 - PubMed
  81. Pharmacol Res. 2002 Sep;46(3):213-19 - PubMed
  82. J Mol Cell Cardiol. 2012 Mar;52(3):660-6 - PubMed
  83. Ann Transl Med. 2017 Aug;5(16):324 - PubMed
  84. Cardiorenal Med. 2017 Oct;7(4):255-266 - PubMed
  85. J Biol Chem. 2008 Aug 29;283(35):24194-201 - PubMed
  86. Cell. 2008 May 2;133(3):462-74 - PubMed
  87. J Proteome Res. 2008 Nov;7(11):5004-16 - PubMed
  88. Int J Cardiol. 2013 Jun 5;166(1):246-8 - PubMed
  89. J Biol Chem. 2001 Feb 16;276(7):4588-96 - PubMed
  90. Biomolecules. 2020 Feb 17;10(2): - PubMed
  91. Int J Mol Sci. 2019 Jul 26;20(15): - PubMed
  92. Sci Rep. 2017 Nov 7;7(1):14747 - PubMed
  93. Circulation. 2017 Mar 7;135(10):e146-e603 - PubMed
  94. Eur Heart J. 2018 Mar 7;39(10):888-898 - PubMed
  95. Antioxid Redox Signal. 2007 Nov;9(11):1825-36 - PubMed
  96. J Biol Chem. 2010 Nov 5;285(45):34447-59 - PubMed

Publication Types

Grant support